Institutional investors purchased a net $54.7 million shares of GILD during the quarter ended September 2016 and now own 77.20% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SUSQUEHANNA FINANCIAL GROUP LLLP Bought 4.7 Million shares of Gilead Sciences
BOSTON PARTNERS GLOBAL INVESTORS... Bought 3.4 Million shares of Gilead Sciences
BLACKROCK ADVISORS LLC Bought 2.8 Million shares of Gilead Sciences